-
1.VERY EFFICIENT PROCESS FOR PREPARING AN INTERMEDIATE OF ETORICOXIB 失效
标题翻译: 用于制备ETORICOXIB中间体的非常有效的方法公开(公告)号:US20140206882A1
公开(公告)日:2014-07-24
申请号:US13924094
申请日:2013-06-21
发明人: Paolo Stabile , Marco Galvagni
IPC分类号: C07D213/52
CPC分类号: C07D213/52 , C07D213/50
摘要: The present invention relates to an efficient process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of the synthesis of Etoricoxib. Water is employed as reaction medium.
摘要翻译: 本发明涉及一种合成Etoricoxib的中间体1-(6-甲基吡啶-3-基)-2- [4-(甲基磺酰基)苯基]乙酮的有效方法。 水用作反应介质。
-
公开(公告)号:US20140024704A1
公开(公告)日:2014-01-23
申请号:US13940931
申请日:2013-07-12
发明人: Andrea Castellin , Clark Ferrari , Marco Galvagni
IPC分类号: C07D313/12
CPC分类号: C07D313/12
摘要: A process for the preparation of olopatadine hydrochloride starting from an advanced intermediate.
摘要翻译: 从高级中间体开始制备盐酸奥洛他定的方法。
-
公开(公告)号:US20180230151A1
公开(公告)日:2018-08-16
申请号:US15429278
申请日:2017-02-10
发明人: Marco Galvagni , Ennio Grendele , Giovanni Lora
IPC分类号: C07D487/04 , A61K31/4985 , C12P7/26
CPC分类号: C07D487/04 , A61K31/4985 , C12P7/26
摘要: An improved process for the preparation of Triazole and salts thereof, a key intermediate for the synthesis of Sitagliptine is disclosed.
-
公开(公告)号:US08980939B2
公开(公告)日:2015-03-17
申请号:US13940931
申请日:2013-07-12
发明人: Andrea Castellin , Clark Ferrari , Marco Galvagni
IPC分类号: C07D313/12
CPC分类号: C07D313/12
摘要: A process for the preparation of olopatadine hydrochloride starting from an advanced intermediate.
摘要翻译: 从高级中间体开始制备盐酸奥洛他定的方法。
-
5.
公开(公告)号:US08765962B1
公开(公告)日:2014-07-01
申请号:US13924094
申请日:2013-06-21
发明人: Paolo Stabile , Marco Galvagni
IPC分类号: C07D213/50
CPC分类号: C07D213/52 , C07D213/50
摘要: The present invention relates to an efficient process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of the synthesis of Etoricoxib. Water is employed as reaction medium.
摘要翻译: 本发明涉及一种合成Etoricoxib的中间体1-(6-甲基吡啶-3-基)-2- [4-(甲基磺酰基)苯基]乙酮的有效方法。 水用作反应介质。
-
公开(公告)号:US09315470B2
公开(公告)日:2016-04-19
申请号:US14395703
申请日:2014-02-11
发明人: Ottorino De Lucchi , Stefano Tartaggia , Clark Ferrari , Marco Galvagni , Marta Pontini , Stefano Fogal , Riccardo Motterle , Rosa Maria Moreno , Alex Comely
IPC分类号: C07D239/42 , C07F7/18 , C07D317/30 , C07D215/14 , C07D209/24 , C07D413/12 , C07D419/12
CPC分类号: C07F7/1804 , B01J27/13 , B01J31/122 , B01J2231/543 , C07D209/12 , C07D209/24 , C07D213/30 , C07D215/14 , C07D239/42 , C07D317/30 , C07D413/12 , C07D419/12 , C07F7/188 , C07F7/1892
摘要: Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of statins.
摘要翻译: 本发明的目的是制备用于合成他汀类药物的关键中间体的改进方法。
-
公开(公告)号:US20130165650A1
公开(公告)日:2013-06-27
申请号:US13777817
申请日:2013-02-26
发明人: Alessandro Leganza , Marco Galvagni
IPC分类号: C07D265/18 , C07C215/70
CPC分类号: C07D265/18
摘要: A process for the preparation of Efavirenz, (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one, of formula (I): comprising reacting the intermediate of formula (II): as a free base or a salt thereof, with diphosgene (TCMCF, trichloromethylchloroformate) Cl3CO—COCl in an organic solvent or in a biphasic medium comprised of an organic solvent and water, preferably but not mandatorily in the presence of a weak base in an amount sufficient to neutralize the reaction mixture or in an up to 30% molar excess of such amount.
摘要翻译: 制备式(I)的依法韦伦,(4S)-6-氯-4-(环丙基乙炔基)-4-(三氟甲基)-1,4-二氢-2H-3,1-苯并恶嗪-2-酮的方法 ):包括使式(II)的中间体:游离碱或其盐与有机溶剂中的双光气(TCMCF,氯甲酸三氯甲酯)Cl 3 CO-COCl反应或由有机溶剂和水组成的双相介质中,优选但不限于 在弱碱存在下,强度不足以中和反应混合物或以高达30%摩尔过量的量存在。
-
8.
公开(公告)号:US20130143890A1
公开(公告)日:2013-06-06
申请号:US13691881
申请日:2012-12-03
发明人: Clark Ferrari , Andrea Castellin , Marco Galvagni , Nicolas Tesson , Jordi De Mier , Llorenç Rafecas
IPC分类号: C07D241/42 , C07D241/12 , C07D239/69
CPC分类号: C07D241/42 , C07D239/42 , C07D239/69 , C07D241/12
摘要: Methods for the preparation of Rosuvastatin by co-crystals of Rosuvastatin or intermediates are provided. Also provided are co-crystals, pharmaceutical compositions which include such co-crystals and methods for treating conditions associated with hypercholesterolemia by administering such compositions.
摘要翻译: 提供了通过罗苏伐他汀或中间体的共晶制备罗苏伐他汀的方法。 还提供了共晶体,包括这种共晶体的药物组合物和通过施用这样的组合物来治疗与高胆固醇血症相关的病症的方法。
-
公开(公告)号:US10047094B1
公开(公告)日:2018-08-14
申请号:US15429278
申请日:2017-02-10
发明人: Marco Galvagni , Ennio Grendele , Giovanni Lora
IPC分类号: C07D487/04 , A61K31/4985 , C12P7/26
摘要: An improved process for the preparation of Triazole and salts thereof, a key intermediate for the synthesis of Sitagliptine is disclosed.
-
公开(公告)号:US09932361B2
公开(公告)日:2018-04-03
申请号:US15063966
申请日:2016-03-08
发明人: Ottorino De Lucchi , Stefano Tartaggia , Clark Ferrari , Marco Galvagni , Marta Pontini , Stefano Fogal , Riccardo Motterle , Rosa Maria Moreno , Alex Comely
IPC分类号: C07F7/18 , C07D239/42 , C07D317/30 , C07D215/14 , C07D209/24 , C07D413/12 , C07D419/12 , B01J27/13 , B01J31/12 , C07D209/12 , C07D213/30
CPC分类号: C07F7/1804 , B01J27/13 , B01J31/122 , B01J2231/543 , C07D209/12 , C07D209/24 , C07D213/30 , C07D215/14 , C07D239/42 , C07D317/30 , C07D413/12 , C07D419/12 , C07F7/188 , C07F7/1892
摘要: Object of the present invention is an improved process for the preparation of key intermediates for the synthesis of statins.
-
-
-
-
-
-
-
-
-